HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 09/28/2012 -- AspenBio Pharma, (NCM:APPY) is very active today and traded between $1.91 - 2.74 with total traded volume of 2317079 shares. At a current price of 2.74, APPYis +0.90 - +48.91% from the previous close of $1.84. Moreover, At Current Market Price, APPY is in distance of +60.07% from its 50-day Moving Average price of $1.7117 and -1.65% from its 200-day Moving Average price of $2.786. For AspenBio Pharma, that hint is a cross above the 100-day moving average line on the best volume we've seen in months. Were it the first time we'd seen such a strong, high-volume move from APPY, it might be dismissible. This is the second time we've seen it happen this month, however, and that's pulled the stock out of a nasty rut. While we may see some sideways movement from the chart again - like we saw in mid September following the first pop - the heavy lifting hasbeen done. APPY is the company that's primarily working on a blood-based appendicitis test, and intends to finalize its deign and begin testing it in Q4. That's part of the reason for the recent surge, but not the whole reason. Investors are mostly celebrating the fact that AspenBio Pharma is outsourcing its other lines of business so it can focus on the development of the test itself. The appendicitis test market - which has seen several failed products in recent years - is estimated to be a billion dollar annual opportunity by some. For comparison, APPYis a $17 million company.
Can APPY Bounce Back From Here : Click Here For Free Report
Royale Energy, In (NCM:ROYL) is +1.07 - +32.92% from the previous close of $3.25. It traded between $4.18 - 5.23 with total traded volume of 6435811 shares. Keep a close eye on ROYL, as the stock has been showing unusual moves over the past weeks. At Current market price, ROYL has recovered +149.71% from its 52-week Low of 1.73 and has Pulled back -38.11% from its 52-week high of 6.98. Royale Energy, Inc. ROYL +32.92% shares soared 39.08% to $4.47 in the morning hour. The company's Co-CEO Stephen Hosmer spoke to delegates at the Alaska Oil and Gas Congress in Anchorage last week. While sharing the stage with CEO of Great Bear Petroleum Operating LLC, Ed Duncan discussed the results of their initial test wells (Alcor #1 and Merak #1) in which they cored portions of the Shublik, HRZ/GRZ, and Kingak shales, the source rock for Alaska's Prudhoe Bay oil field.
Will ROYL Continue To Move Higher? Find Out Here
Tempur-pedic Inte (NYSE:TPX) reported EPS of 3.065. For the Current Fiscal year, the company is expected to report EPS of 2.79. For the Next Quarter and Next Year, the company is expected to report EPS of 0.80 and 3.11 respectively. At Current Market Price, TPX is in distance of -3.65% from its 50-day Moving Average price of $31.8023 and -31.64% from its 200-day Moving Average price of $44.8246. Tempur-Pedic International Inc.(NYSE:TPX) shares soared 21.28% to $32.48 after TPX and Sealy Corp announced that they have signed a definitive agreement to create a $2.7 billion global bedding provider. The transaction has been approved by the Boards of Directors of both companies. Tempur-Pedic will acquire all of the outstanding common stock of Sealy for $2.20 per share.The transaction is expected to close during the first half of 2013.
Is TPX Get A Support From Here And Continue To Move Upside : Find Out Here
Progress Software (NasdaqNM:PRGS) is very active today and traded between $20.06 - 22.24 with total traded volume of 1786796 shares. At a current price of 21.23, PRGS is +2.07 - +10.80% from the previous close of $19.16. Moreover, At Current Market Price, PRGS is in distance of +6.57% from its 50-day Moving Average price of $19.9217 and +2.03% from its 200-day Moving Average price of $20.8081. of 67.72. Progress Software Corp. Progress Software (PRGS) are up 11%, adding to earlier gains of 3%, after the company reported Q3 non-GAAP EPS from continuing operations of $0.31. That beat the $0.24 a share gain expected by analysts but was a penny shy of the year-ago per-share profit. Revenue declined 9% year over year to $107.2 million, trailing estimates by $5.12 million. Looking forward, Q4 core revenue growth is expected in a range of -2% to 1% from year-ago levels. Analysts, on average, are expecting $125.13 million in Q4 sales. Core segment operating margin is expected to be in the range of 25% to 30%.
Is PRGS Touches Its Previous High : Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)